subchapter 26F – controlled substances

Link to law: http://reports.oah.state.nc.us/ncac/title 10a - health and human services/chapter 26 - mental health, general/subchapter f/10a ncac 26f .0101.html
Published: 2015

Subscribe to a Global-Regulation Premium Membership Today!

Key Benefits:

Subscribe Now
subchapter 26F – controlled substances

 

SECTION .0100 ‑ SCHEDULES OF CONTROLLED SUBSTANCES

 

10A NCAC 26F .0101        DEFINITIONS

As used in this Section, the following terms shall have the

meanings specified:

(1)           The term "act" means the North Carolina Controlled

Substances Act (G.S. Chapter 90, Article 5).

(2)           The term "basic class" means, as to

controlled substances listed in Schedules I, II and VI:

(a)           Each of the opiates, including its isomers,

esters, ethers, salts and salts of isomers, esters, ethers and salts is

possible within the specific chemical designation listed in Schedule I of the

North Carolina Controlled Substances Act;

(b)           Each of the opium derivatives, including its

salts, isomers and salts of isomers whenever the existence of such salts,

isomers and salts of isomers is possible within the specific chemical

designation listed in Schedule I of the North Carolina Controlled Substances

Act;

(c)           Each of the hallucinogenic substances,

including its salts, isomers and salts of isomers whenever the existence of

such salts, isomers and salts of isomers is possible within the specific

chemical designation listed in Schedule I of the North Carolina Controlled

Substances Act;

(d)           Each of the following substances, whether

produced directly or indirectly by extraction from substances of vegetable

origin, or independently by means of chemical synthesis or by a combination of

extraction and chemical synthesis:

(i)            opium, including raw opium, opium extracts,

opium fluid extracts, powdered opium, granulated opium, deodorized opium and

tincture of opium;

(ii)           apomorphine;

(iii)          codeine;

(iv)          etorphine hydrochloride;

(v)           ethylmorphine;

(vi)          hydrocodone;

(vii)         hydromorphine;

(viii)        metopon;

(ix)          morphine;

(x)           oxycodone;

(xi)          oxymorphone;

(xii)         thebaine;

(xiii)        mixed alkaloids of opium listed in Schedule

I of the North Carolina Controlled Substances Act;

(xiv)        cocaine; and

(xv)         ecgonine;

(e)           Each of the opiates, including its isomers,

esters, ethers, salts and salts of isomers, esters and ethers whenever the existence

of such isomers, esters and ethers, and salts is possible within the specific

chemical designation, listed in Schedule II of the North Carolina Controlled

Substances Act;

(f)            Methamphetamine, its salts, isomers and

salts of its isomers;

(g)           Amphetamine, its salts, optical isomers and

salts of its optical isomers;

(h)           Phenmetrazine and its salts;

(i)            Methylphenidate;

(j)            Each of the substances having a depressant

effect on the central nervous system, including its salts, isomers and salts of

isomers whenever the existence of such salts, isomers and salts of isomers is

possible within the specific chemical designation listed in Rule .0205 of this

Section.

(3)           The term "hearing" means any hearing held

pursuant to this part for the addition, deletion or rescheduling of any

substances within Schedules I through VI of the North Carolina Controlled

Substances Act.

(4)           The term "isomer" means, except as used

in Paragraph .0202(d) of this Section, the optical isomer.  As used in

Paragraph .0202(d) of this Section, the term "isomer" means the

optical, position or geometric isomer.

(5)           The term "interested person" means any

person affected by any decision issuable pursuant to General Statute 90‑88.

(6)           The term "proceeding" means all actions

taken for the addition, deletion, or rescheduling of any substance within

Schedules I through VI of the North Carolina Controlled Substances Act, issued

pursuant to General Statute 90‑88, commencing with the publication by the

Commission for Mental Health, Developmental Disabilities and Substance Abuse

Services of the proposed addition, deletion or rescheduling.

(7)           The term anabolic steroid means any drug or

hormonal substance, chemically and pharmacologically related to testosterone

(other than estrogens, progestins, and corticosteroids) that promotes muscle

growth, and includes:

(a)           Boldenone;

(b)           Chlorotestosterone (4‑chlortestosterone);

(c)           Clostebol;

(d)           Dehydrochlormethyltestosterone;

(e)           Dihydrotestosterone (4‑dihydrotestosterone);

(f)            Drostanolone;

(g)           Ethylestrenol;

(h)           Fluoxymesterone;

(i)            Formebulone (formebolone);

(j)            Mesterolone;

(k)           Methandienone;

(l)            Methandranone;

(m)          Methandriol;

(n)           Methandrostenolone;

(o)           Methenolone;

(p)           Methyltestosterone;

(q)           Mibolerone;

(r)            Nandrolone;

(s)            Norethandrolone;

(t)            Oxandrolone;

(u)           Oxymesterone;

(v)           Oxymetnolone;

(w)          Stanolone;

(x)           Stanozolol;

(y)           Testolactone;

(z)           Testosterone;

(aa)         Trenbolone; and

(bb)         Any salt, ester, or isomer of a drug or

substance described or listed in this Paragraph, if that salt, ester, or isomer

promotes muscle growth.  Except such term does not include an anabolic steroid

which is expressly intended for administration through implants to cattle or

other nonhuman species and which has been approved by the Secretary of Health

and Human Services for such administration.  If any person prescribes,

dispenses, or distributes such steroid for human use, such person shall be

considered to have prescribed, dispensed, or distributed an anabolic steroid

within the meaning of this Paragraph.

(8)           Any term not defined in this Rule shall have the

definition set forth in General Statute 90‑87.

 

History Note:        Authority G.S. 90‑88;

Eff. June 30, 1978;

Amended Eff. September 1, 1998; August 1, 1991; May 1,

1990.